Perini P - Search Results

1

Early red nucleus atrophy in relapse-onset multiple sclerosis.

Margoni M, Poggiali D, Zywicki S, Rubin M, Lazzarotto A, Franciotta S, Anglani MG, Causin F, Rinaldi F, Perini P, Filippi M, Gallo P. Margoni M, et al. Among authors: perini p. Hum Brain Mapp. 2021 Jan;42(1):154-160. doi: 10.1002/hbm.25213. Epub 2020 Oct 13. Hum Brain Mapp. 2021. PMID: 33047810 Free PMC article.

2

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.

Ferrarini AM, Sivieri S, Buttarello M, Facchinetti A, Perini P, Gallo P. Ferrarini AM, et al. Among authors: perini p. Mult Scler. 1998 Jun;4(3):174-7. doi: 10.1177/135245859800400316. Mult Scler. 1998. PMID: 9762669

3

Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.

Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P. Perini P, et al. Eur Cytokine Netw. 2000 Mar;11(1):81-6. Eur Cytokine Netw. 2000. PMID: 10705303 Free article.

4

Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients.

Perini P, Wadhwa M, Buttarello M, Meager A, Facchinetti A, Thorpe R, Biasi G, Gallo P. Perini P, et al. J Neuroimmunol. 2000 Jun 1;105(1):91-5. doi: 10.1016/s0165-5728(00)00196-x. J Neuroimmunol. 2000. PMID: 10713368

5

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.

Perini P, Facchinetti A, Bulian P, Massaro AR, Pascalis DD, Bertolotto A, Biasi G, Gallo P. Perini P, et al. Eur Cytokine Netw. 2001 Mar;12(1):56-61. Eur Cytokine Netw. 2001. PMID: 11282547 Free article.

6

The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy.

Perini P, Tagliaferri C, Belloni M, Biasi G, Gallo P. Perini P, et al. Neurology. 2001 Jul 10;57(1):158-9. doi: 10.1212/wnl.57.1.158. Neurology. 2001. PMID: 11445652 No abstract available.

7

The range of multiple sclerosis associated with neurofibromatosis type 1.

Perini P, Gallo P. Perini P, et al. J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):679-81. doi: 10.1136/jnnp.71.5.679. J Neurol Neurosurg Psychiatry. 2001. PMID: 11606684 Free PMC article.

8

Cerebrospinal fluid examination in the differential diagnosis of inflammatory myelopathies.

Perini P, Calabrese M, Ranzato F, Tiberio M, Gallo P. Perini P, et al. Neurol Sci. 2001 Nov;22 Suppl 2:S65-8. doi: 10.1007/s100720100037. Neurol Sci. 2001. PMID: 11794481 Review.

9

Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.

Perini P, Gallo P. Perini P, et al. J Neurol. 2003 Jul;250(7):834-8. doi: 10.1007/s00415-003-1089-x. J Neurol. 2003. PMID: 12883926

10

Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey.

Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Ermani M, Davetag F, De Zanche L, Garbin E, Verdelli F, Villacara A, Volpe G, Moretto G, Gallo P. Ranzato F, et al. Among authors: perini p. Mult Scler. 2003 Aug;9(4):387-92. doi: 10.1191/1352458503ms920oa. Mult Scler. 2003. PMID: 12926844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters